1-9 of 9
Valerie Speirs
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract OT1-04-01: ATNEC: A multi-centre, randomised trial investigating whether axillary treatment can be avoided in T1-3N1M0 breast cancer patients with no residual cancer in the lymph glands after neoadjuvant chemotherapy (clinicaltrials.gov: nct04109079)

Amit Goyal, Sophie Cramp, Andrea Marshall, Duncan Wheatley, Natalie Hammonds, Shama Puri, Tara Homer, Luke Vale, Roeum Butt, Romaana Mir, Janice Rose, Helen Teresa Edwards, Samreen Ahmed, Abeer Shaaban, Beatrix Elsberger, Julie Bruce, Sophie Gasson, Valerie Speirs, Jacqui Shaw, Helen Higgins, Janet Dunn
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT1-04-01.
https://doi.org/10.1158/1538-7445.SABCS21-OT1-04-01
Published: 15 February 2022
View article titled, Abstract OT1-04-01: ATNEC: A multi-centre, randomised trial investigating whether axillary treatment can be avoided in T1-3N1M0 breast cancer patients with no residual cancer in the lymph glands after neoadjuvant chemotherapy (clinicaltrials.gov: nct04109079)
Journal Articles

Abstract OT-04-01: Axillary management in T1-3N1M0 breast cancer patients with needle biopsy proven nodal metastases at presentation after neoadjuvant chemotherapy - ATNEC (ClinicalTrials.gov NCT04109079)

Amit Goyal, Sophie Cramp, Duncan Wheatley, Andrea Marshall, Shama Puri, Tara Homer, Luke Vale, Romaana Mir, Zohal Nabi, Janice Rose, Helen Teresa Edwards, Samreen Ahmed, Abeer Shaaban, Beatrix Elsberger, Julie Bruce, Sophie Gasson, Valerie Speirs, Jacqui Shaw, Helen Higgins, Janet Dunn
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): OT-04-01.
https://doi.org/10.1158/1538-7445.SABCS20-OT-04-01
Published: 15 February 2021
View article titled, Abstract OT-04-01: Axillary management in T1-3N1M0 breast cancer patients with needle biopsy proven nodal metastases at presentation after neoadjuvant chemotherapy - ATNEC (ClinicalTrials.gov NCT04109079)
Journal Articles

Abstract P1-12-12: The insulin like growth factor axis and development of tamoxifen resistance in breast cancer

Yousef M Hawsawi, James Beattie, Reem El-Gendy, Valerie Speirs, Christopher Twelves
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P1-12-12.
https://doi.org/10.1158/1538-7445.SABCS14-P1-12-12
Published: 01 May 2015
View article titled, Abstract P1-12-12: The insulin like growth factor axis and development of tamoxifen resistance in breast cancer
Journal Articles

Abstract 2505: Expression profiling of cofilin-1 in breast cancer cell lines and biopsies.

Chris Sutton, Sadr ul-Shaheed, Paul Loadman, Valerie Speirs, Andrew Hanby, Andreas Hadjisavvas, Kyriacos Kyriacou
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2505.
https://doi.org/10.1158/1538-7445.AM2013-2505
Published: 15 April 2013
View article titled, Abstract 2505: Expression profiling of cofilin-1 in breast cancer cell lines and biopsies.
Journal Articles

Estrogen Receptor β1 Expression Is Regulated by miR-92 in Breast Cancer

Hakeemah Al-Nakhle, Philip A. Burns, Michele Cummings, Andrew M. Hanby, Thomas A. Hughes, Sampoorna Satheesha, Abeer M. Shaaban, Laura Smith, Valerie Speirs
Journal: Cancer Research
Cancer Res (2010) 70 (11): 4778–4784.
https://doi.org/10.1158/0008-5472.CAN-09-4104
Published: 01 June 2010
View article titled, Estrogen Receptor β1 Expression Is Regulated by miR-92 in Breast Cancer
Open the PDF for Estrogen Receptor β1 Expression Is Regulated by miR-92 in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

A genetic and proteomic approach to identify factors involved in Tamoxifen responsiveness

Daniel J. Scott, Alicia T. Parkes, Claire E. Murphy, Rachel A. Craven, Rosamonde E. Banks, Indra Poola, Valerie Speirs
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 139.
Published: 01 April 2004
View article titled, A genetic and proteomic approach to identify factors involved in Tamoxifen responsiveness
Journal Articles

Correspondence re: S. A. W. Fuqua et al ., Estrogen Receptor β Protein in Human Breast Cancer: Correlation with Clinical Tumor Parameters. Cancer Res., 63: 2434–2439, 2003.

Valerie Speirs
Journal: Cancer Research
Cancer Res (2003) 63 (24): 9055.
Published: 24 December 2003
View article titled, Correspondence re: S. A. W. Fuqua <em>et al</em> ., Estrogen Receptor β Protein in Human Breast Cancer: Correlation with Clinical Tumor Parameters. Cancer Res., <em>63:</em> 2434–2439, 2003.
Open the PDF for Correspondence re: S. A. W. Fuqua <em>et al</em> ., Estrogen Receptor β Protein in Human Breast Cancer: Correlation with Clinical Tumor Parameters. Cancer Res., <em>63:</em> 2434–2439, 2003. in another window
Journal Articles

Increased Expression of Estrogen Receptor β mRNA in Tamoxifen-resistant Breast Cancer Patients

Valerie Speirs, Carmel Malone, David S. Walton, Michael J. Kerin, Stephen L. Atkin
Journal: Cancer Research
Cancer Res (1999) 59 (21): 5421–5424.
Published: 01 November 1999
View article titled, Increased Expression of Estrogen Receptor β mRNA in Tamoxifen-resistant Breast Cancer Patients
Open the PDF for Increased Expression of Estrogen Receptor β mRNA in Tamoxifen-resistant Breast Cancer Patients in another window
Journal Articles

Coexpression of Estrogen Receptor α and β: Poor Prognostic Factors in Human Breast Cancer?

Valerie Speirs, Alicia T. Parkes, Michael J. Kerin, David S. Walton, Peter J. Carleton, John N. Fox, Stephen L. Atkin
Journal: Cancer Research
Cancer Res (1999) 59 (3): 525–528.
Published: 01 February 1999
View article titled, Coexpression of Estrogen Receptor α and β: <subtitle>Poor Prognostic Factors in Human Breast Cancer?</subtitle>
Open the PDF for Coexpression of Estrogen Receptor α and β: <subtitle>Poor Prognostic Factors in Human Breast Cancer?</subtitle> in another window